Literature DB >> 31596739

Emerging Role of Myeloid-derived Suppressor Cells in the Biology of Transplantation Tolerance.

Liang Shao1, Shan Pan2, Qiu-Ping Zhang2, Muhammad Jamal2, Gerard-Martin Rushworth3, Jie Xiong2, Rui-Jing Xiao2, Jia-Xing Sun2, Qian Yin2, Ying-Jie Wu2, Albert K W Lie4.   

Abstract

Myeloid-derived suppressor cells (MDSCs), a heterogeneous population of myeloid cells, are characterized by their immunosuppressive abilities through the secretion of various cytokines such as inducible nitric oxide synthase, nitric oxide, reactive oxygen species, transforming growth factor-β, and arginase-1. Accumulating evidence highlights its potential role in maintaining immune tolerance in solid organ and hematopoietic stem cell transplantation. Mechanistically, MDSCs-induced transplant tolerance is mainly dependent on direct suppression of allogeneic reaction or strengthened cross-talk between MDSCs and Treg or NKT cells. Adopted transfer of in vitro- or in vivo-induced MDSCs by special drugs therefore becomes a potential strategy for maintaining transplantation tolerance. In this review, we will summarize the previously published data about the role of MDSCs in the biology of transplantation tolerance and gain insights into the possible molecular mechanism governing this process.

Entities:  

Mesh:

Year:  2020        PMID: 31596739     DOI: 10.1097/TP.0000000000002996

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity.

Authors:  Andreas Schroeter; Maximilian J Roesel; Tomohisa Matsunaga; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 2.  Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.

Authors:  Jilu Zhang; Alan Hodges; Shu-Hsia Chen; Ping-Ying Pan
Journal:  Cell Immunol       Date:  2021-02-04       Impact factor: 4.868

3.  Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Authors:  Maite Alvarez; Antonio Pierini; Federico Simonetta; Jeanette Baker; Kristina Maas-Bauer; Toshihito Hirai; Robert S Negrin
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.